AUPH logo

Aurinia Pharmaceuticals (AUPH) Net Income

Annual Net Income

-$78.02 M
+$30.16 M+27.88%

December 31, 2023

Summary

Performance

1-Year Change

+27.88%

3-Year Change

+24.02%

5-Year Change

-46.99%

15-Year Change

-10.21%

AUPH Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

26.59%
AUPH annual net profit is higher than 26.59% of companies in Healthcare sector

High & Low

All-time High

-$365.90 K

3-Year Low

-$180.97 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
AUPH previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 14, 2025
AUPH next annual earnings announcement is scheduled for Feb 14, 2025

OtherAUPHprofitabilitymetrics:

Annual Net Margin

-44.45%
AUPH annual net profit margin is -44.45%

Annual Revenue

$175.51 M
AUPH annual revenue is $175.51 million

Annual Gross Profit

$161.37 M
AUPH annual gross profit is $161.37 million

Annual EPS

-$0.54
AUPH annual earnings per share is -$0.54

Quarterly Net Income

$14.35 M
+$13.63 M+1887.53%

September 30, 2024

Summary

Performance

3-Month Change

+1887.53%

1-Year Change

+1887.53%

3-Year Change

+259.64%

5-Year Change

+259.64%

AUPH Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.38%
AUPH quarterly net profit is higher than 87.38% of companies in Healthcare sector

High & Low

All-time High

$14.35 M
AUPH quarterly net profit is currently at an all-time high

3-Year Low

-$37.63 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AUPH previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
AUPH next earnings announcement is scheduled for Feb 14, 2025

OtherAUPHprofitabilitymetrics:

Quarterly Net Margin

21.17%
AUPH quarterly net profit margin is 21.17%

Quarterly Revenue

$67.77 M
AUPH quarterly revenue is $67.77 million

Quarterly Gross Profit

$61.74 M
AUPH quarterly gross profit is $61.74 million

Quarterly EPS

$0.10
AUPH quarterly earnings per share is $0.10

TTM Net Income

-$22.55 M
+$27.80 M+55.21%

September 30, 2024

Summary

Performance

3-Month Change

+55.21%

1-Year Change

+55.21%

3-Year Change

+80.47%

5-Year Change

+80.47%

AUPH TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

53.68%
AUPH TTM net profit is higher than 53.68% of companies in Healthcare sector

High & Low

All-time High

$3.30 M
AUPH TTM net profit is currently -782.46% below its historical high of $3.30 million

3-Year Low

-$180.97 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AUPH previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
AUPH next earnings announcement is scheduled for Feb 14, 2025

OtherAUPHprofitabilitymetrics:

Annual Net Margin

-44.45%
AUPH annual net profit margin is -44.45%

TTM Revenue

$220.36 M
AUPH TTM revenue is $220.36 million

TTM Gross Profit

$192.27 M
AUPH TTM gross profit is $192.27 million

TTM EPS

-$0.14
AUPH TTM earnings per share is -$0.14

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$78.02 M
AUPH annual net profit is -$78.02 million

Annual Revenue

$175.51 M
AUPH annual revenue is $175.51 million

Annual Cost Of Goods Sold

$14.15 M
AUPH annual cost of goods sold is $14.15 million

Annual Operating Expenses

$253.06 M
AUPH annual total operating expenses is $253.06 million

Annual Interest Expense

$2.77 M
AUPH annual interest expense is $2.77 million

Annual Income Tax

$551.00 K
AUPH annual income tax is $551.00 thousand

AUPH Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+27.9%+1887.5%+55.2%
3 y3 years+24.0%+259.6%+80.5%
5 y5 years-47.0%+259.6%+80.5%

AUPH Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+56.9%at high+138.1%at high+87.5%
5 y5-yearat high+56.9%at high+128.5%at high+87.5%
alltimeall time<-9999.0%+56.9%at high+127.6%-782.5%+87.5%

Aurinia Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
$14.35 M(+1887.5%)
-$22.55 M(-55.2%)
Jun 2024
-
$722.00 K(-106.7%)
-$50.35 M(-19.5%)
Mar 2024
-
-$10.75 M(-60.0%)
-$62.56 M(-19.8%)
Dec 2023
-$78.02 M(-27.9%)
-$26.88 M(+99.9%)
-$78.02 M(+1.1%)
Sep 2023
-
-$13.45 M(+17.0%)
-$77.19 M(+6.1%)
Jun 2023
-
-$11.49 M(-56.1%)
-$72.73 M(-24.8%)
Mar 2023
-
-$26.21 M(+0.6%)
-$96.76 M(-10.6%)
Dec 2022
-$108.18 M(-40.2%)
-$26.05 M(+189.8%)
-$108.18 M(-6.3%)
Sep 2022
-
-$8.99 M(-74.7%)
-$115.46 M(-26.3%)
Jun 2022
-
-$35.52 M(-5.6%)
-$156.72 M(-6.8%)
Mar 2022
-
-$37.63 M(+12.9%)
-$168.22 M(-7.0%)
Dec 2021
-$180.97 M(+76.2%)
-$33.32 M(-33.7%)
-$180.97 M(+16.2%)
Sep 2021
-
-$50.26 M(+6.9%)
-$155.72 M(+5.5%)
Jun 2021
-
-$47.01 M(-6.7%)
-$147.59 M(+16.1%)
Mar 2021
-
-$50.38 M(+524.0%)
-$127.13 M(+23.8%)
Dec 2020
-$102.68 M(+16.2%)
-$8.07 M(-80.8%)
-$102.68 M(-24.3%)
Sep 2020
-
-$42.13 M(+58.7%)
-$135.63 M(+20.5%)
Jun 2020
-
-$26.54 M(+2.4%)
-$112.53 M(+10.4%)
Mar 2020
-
-$25.93 M(-36.8%)
-$101.89 M(+15.3%)
Dec 2019
-$88.39 M(+66.5%)
-$41.02 M(+115.5%)
-$88.39 M(+73.6%)
Sep 2019
-
-$19.04 M(+19.7%)
-$50.92 M(+1.4%)
Jun 2019
-
-$15.90 M(+27.9%)
-$50.22 M(+0.4%)
Mar 2019
-
-$12.43 M(+249.9%)
-$50.03 M(-5.7%)
Dec 2018
-$53.08 M(-25.0%)
-$3.55 M(-80.6%)
-$53.08 M(+0.4%)
Sep 2018
-
-$18.34 M(+16.8%)
-$52.86 M(+11.0%)
Jun 2018
-
-$15.71 M(+1.5%)
-$47.64 M(+38.8%)
Mar 2018
-
-$15.48 M(+364.5%)
-$34.33 M(-51.5%)
Dec 2017
-$70.79 M(+203.9%)
-$3.33 M(-74.6%)
-$70.79 M(-6.6%)
Sep 2017
-
-$13.12 M(+446.9%)
-$75.79 M(+8.1%)
Jun 2017
-
-$2.40 M(-95.4%)
-$70.09 M(-1.2%)
Mar 2017
-
-$51.94 M(+523.3%)
-$70.97 M(+204.7%)
Dec 2016
-$23.30 M(+25.2%)
-$8.33 M(+12.3%)
-$23.30 M(+22.4%)
Sep 2016
-
-$7.42 M(+126.5%)
-$19.02 M(+13.1%)
Jun 2016
-
-$3.28 M(-23.2%)
-$16.82 M(+17.8%)
Mar 2016
-
-$4.27 M(+5.0%)
-$14.27 M(-23.3%)
Dec 2015
-$18.61 M(-4.2%)
-$4.06 M(-22.0%)
-$18.61 M(-17.8%)
Sep 2015
-
-$5.21 M(+610.8%)
-$22.65 M(+74.2%)
Jun 2015
-
-$733.00 K(-91.5%)
-$13.00 M(-44.2%)
Mar 2015
-
-$8.60 M(+6.1%)
-$23.30 M(+19.6%)
Dec 2014
-$19.42 M(+629.6%)
-$8.11 M(-282.6%)
-$19.48 M(+49.0%)
Sep 2014
-
$4.44 M(-140.2%)
-$13.07 M(-21.8%)
Jun 2014
-
-$11.03 M(+131.1%)
-$16.71 M(+151.3%)
Mar 2014
-
-$4.78 M(+181.2%)
-$6.65 M(+149.8%)
Dec 2013
-$2.66 M(-72.7%)
-$1.70 M(-314.4%)
-$2.66 M(-56.6%)
Sep 2013
-
$792.00 K(-181.6%)
-$6.13 M(-29.1%)
Jun 2013
-
-$970.00 K(+23.4%)
-$8.65 M(-13.4%)
Mar 2013
-
-$786.00 K(-84.8%)
-$9.99 M(+3.4%)
Dec 2012
-$9.74 M(+304.5%)
-$5.17 M(+198.8%)
-$9.65 M(-10.8%)
Sep 2012
-
-$1.73 M(-24.9%)
-$10.82 M(+56.1%)
Jun 2012
-
-$2.30 M(+406.3%)
-$6.93 M(-2866.3%)
Mar 2012
-
-$455.00 K(-92.8%)
$250.50 K(-111.0%)
Dec 2011
-$2.41 M
-$6.33 M(-393.1%)
-$2.27 M(-168.7%)
DateAnnualQuarterlyTTM
Sep 2011
-
$2.16 M(-55.7%)
$3.30 M(-248.5%)
Jun 2011
-
$4.88 M(-263.8%)
-$2.22 M(-71.2%)
Mar 2011
-
-$2.98 M(+293.8%)
-$7.71 M(+103.1%)
Dec 2010
-$3.82 M(-49.7%)
-$755.90 K(-77.6%)
-$3.80 M(-18.3%)
Sep 2010
-
-$3.37 M(+451.5%)
-$4.65 M(+56.8%)
Jun 2010
-
-$610.90 K(-165.1%)
-$2.97 M(+7.4%)
Mar 2010
-
$937.80 K(-158.3%)
-$2.76 M(-60.4%)
Dec 2009
-$7.60 M(-52.2%)
-$1.61 M(-4.5%)
-$6.97 M(-7.8%)
Sep 2009
-
-$1.68 M(+314.4%)
-$7.56 M(-19.5%)
Jun 2009
-
-$406.60 K(-87.6%)
-$9.39 M(-34.4%)
Mar 2009
-
-$3.27 M(+48.7%)
-$14.32 M(-11.8%)
Dec 2008
-$15.88 M(-53.0%)
-$2.20 M(-37.4%)
-$16.23 M(-28.3%)
Sep 2008
-
-$3.51 M(-34.2%)
-$22.63 M(-14.7%)
Jun 2008
-
-$5.34 M(+2.9%)
-$26.54 M(-13.1%)
Mar 2008
-
-$5.19 M(-39.7%)
-$30.52 M(-4.8%)
Dec 2007
-$33.82 M(+48.0%)
-$8.60 M(+16.0%)
-$32.06 M(+9.5%)
Sep 2007
-
-$7.41 M(-20.5%)
-$29.28 M(+4.1%)
Jun 2007
-
-$9.32 M(+38.7%)
-$28.13 M(+13.5%)
Mar 2007
-
-$6.72 M(+15.5%)
-$24.79 M(+9.4%)
Dec 2006
-$22.85 M(-21.4%)
-$5.82 M(-7.1%)
-$22.66 M(-8.5%)
Sep 2006
-
-$6.26 M(+4.7%)
-$24.76 M(-3.0%)
Jun 2006
-
-$5.98 M(+30.1%)
-$25.54 M(-2.1%)
Mar 2006
-
-$4.60 M(-41.9%)
-$26.08 M(-8.3%)
Dec 2005
-$29.08 M(+28.9%)
-$7.92 M(+12.4%)
-$28.44 M(-2.7%)
Sep 2005
-
-$7.04 M(+8.0%)
-$29.24 M(-0.6%)
Jun 2005
-
-$6.52 M(-6.4%)
-$29.43 M(+11.8%)
Mar 2005
-
-$6.97 M(-20.0%)
-$26.32 M(+18.3%)
Dec 2004
-$22.56 M(+54.0%)
-$8.71 M(+20.5%)
-$22.25 M(+9.6%)
Sep 2004
-
-$7.23 M(+112.0%)
-$20.30 M(+14.7%)
Jun 2004
-
-$3.41 M(+17.6%)
-$17.69 M(+34.6%)
Mar 2004
-
-$2.90 M(-57.1%)
-$13.15 M(-8.0%)
Dec 2003
-$14.65 M(+3902.8%)
-$6.76 M(+46.1%)
-$14.30 M(+38.6%)
Sep 2003
-
-$4.62 M(-507.1%)
-$10.31 M(+222.4%)
Jun 2003
-
$1.14 M(-128.0%)
-$3.20 M(+42.9%)
Mar 2003
-
-$4.05 M(+45.9%)
-$2.24 M(+753.1%)
Dec 2002
-$365.90 K(-95.1%)
-$2.78 M(-211.5%)
-$262.40 K(-110.4%)
Sep 2002
-
$2.49 M(+18.8%)
$2.51 M(-218.7%)
Jun 2002
-
$2.10 M(-201.1%)
-$2.12 M(-71.1%)
Mar 2002
-
-$2.07 M(-3.1%)
-$7.32 M(-25.4%)
Dec 2001
-$7.40 M(+17.8%)
-
-
Aug 2001
-
-$2.14 M(-31.0%)
-$9.81 M(+7.6%)
May 2001
-
-$3.10 M(+46.1%)
-$9.12 M(+18.7%)
Feb 2001
-
-$2.12 M(-13.0%)
-$7.68 M(+21.6%)
Nov 2000
-$6.28 M(+414.1%)
-$2.44 M(+68.8%)
-$6.31 M(+32.6%)
Aug 2000
-
-$1.45 M(-13.3%)
-$4.76 M(+46.6%)
May 2000
-
-$1.67 M(+120.1%)
-$3.25 M(+58.1%)
Feb 2000
-
-$758.10 K(-14.6%)
-$2.05 M(+67.1%)
Nov 1999
-$1.22 M(-44.8%)
-$887.80 K(-1427.1%)
-$1.23 M(+260.0%)
Aug 1999
-
$66.90 K(-114.1%)
-$341.50 K(-16.4%)
May 1999
-
-$474.70 K(-816.0%)
-$408.40 K(-716.0%)
Feb 1999
-
$66.30 K
$66.30 K
Nov 1998
-$2.21 M
-
-

FAQ

  • What is Aurinia Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals annual net income year-on-year change?
  • What is Aurinia Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals quarterly net income year-on-year change?
  • What is Aurinia Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals TTM net income year-on-year change?

What is Aurinia Pharmaceuticals annual net profit?

The current annual net income of AUPH is -$78.02 M

What is the all time high annual net income for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high annual net profit is -$365.90 K

What is Aurinia Pharmaceuticals annual net income year-on-year change?

Over the past year, AUPH annual net profit has changed by +$30.16 M (+27.88%)

What is Aurinia Pharmaceuticals quarterly net profit?

The current quarterly net income of AUPH is $14.35 M

What is the all time high quarterly net income for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high quarterly net profit is $14.35 M

What is Aurinia Pharmaceuticals quarterly net income year-on-year change?

Over the past year, AUPH quarterly net profit has changed by +$13.63 M (+1887.53%)

What is Aurinia Pharmaceuticals TTM net profit?

The current TTM net income of AUPH is -$22.55 M

What is the all time high TTM net income for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high TTM net profit is $3.30 M

What is Aurinia Pharmaceuticals TTM net income year-on-year change?

Over the past year, AUPH TTM net profit has changed by +$27.80 M (+55.21%)